This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. MRNA inched 0.03% higher to $158.07 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.08% to 12,162.59 and the Dow Jones Industrial Average DJIA rising 1.03% to 32,529.63. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $339.42 below its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Thursday, as AbbVie Inc. ABBV fell 0.93% to $149.75, Amgen Inc. AMGN fell 0.78% to $249.75, and AstraZeneca PLC ADR AZN fell 1.14% to $66.72. Trading volume (3.5 M) remained 1.8 million below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2022.
(END) Dow Jones Newswires
July 28, 2022 16:31 ET (20:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.